---
figid: PMC4892113__fphar-07-00147-g0001
figtitle: Single-step pharmacologic strategies in chronic respiratory disease of approved
  and under-development EGFR pathway inhibitors compared to spermidine activity
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4892113
filename: fphar-07-00147-g0001.jpg
figlink: /pmc/articles/PMC4892113/figure/F1/
number: F1
caption: 'Single-step pharmacologic strategies in chronic respiratory disease of approved
  and under-development EGFR pathway inhibitors compared to spermidine activity. Single
  step strategies: (i) anti-EGFR monoclonal antibodies that bind the extracellular
  domain of EGFR and prevent downstream activation (cetuximab, trastuzumab); (ii)
  tyrosine kinase inhibitors targeting the intracellular portion of EGF receptors
  to block autophosphorylation (erlotinib, gefitinib, lapatinib, HKI-272, BIBW-2948);
  (iii) Inhibitors of specific downstream EGFR signaling pathway (ARRY-142886, PX-866,
  ruxolitinib, perifosine, selumetinib, and sorafenib). Acting on TCPTP, spermidine
  can exert multiple direct and indirect effects.'
papertitle: Soft TCPTP Agonismâ€”Novel Target to Rescue Airway Epithelial Integrity
  by Exogenous Spermidine.
reftext: Carlo A. Ghisalberti, et al. Front Pharmacol. 2016;7:147.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9508449
figid_alias: PMC4892113__F1
figtype: Figure
redirect_from: /figures/PMC4892113__F1
ndex: 9d7be1dc-de9b-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4892113__fphar-07-00147-g0001.html
  '@type': Dataset
  description: 'Single-step pharmacologic strategies in chronic respiratory disease
    of approved and under-development EGFR pathway inhibitors compared to spermidine
    activity. Single step strategies: (i) anti-EGFR monoclonal antibodies that bind
    the extracellular domain of EGFR and prevent downstream activation (cetuximab,
    trastuzumab); (ii) tyrosine kinase inhibitors targeting the intracellular portion
    of EGF receptors to block autophosphorylation (erlotinib, gefitinib, lapatinib,
    HKI-272, BIBW-2948); (iii) Inhibitors of specific downstream EGFR signaling pathway
    (ARRY-142886, PX-866, ruxolitinib, perifosine, selumetinib, and sorafenib). Acting
    on TCPTP, spermidine can exert multiple direct and indirect effects.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - hop
  - bsk
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - Akt
  - Dsor1
  - Mtk
  - Stat92E
  - Erk7
  - rl
  - sgg
  - EGFR
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PTPN2
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - EPHB2
  - MAPK1
  - MAPK3
  - GSK3A
  - GSK3B
  - Perifosine
  - ARRY-142886
  - Selumetinib
  - Ruxolitinib
  - Spermidine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
